Assignee
OCUTERRA THERAPEUTICS INC
US·5 granted patents·2 pending applications·3 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0192US11685737B2Fluorinated integrin antagonistsOCUTERRA THERAPEUTICS INC·Filed 2020·Granted Jun 27, 2023·2 cites·25 claims
- 0286US12497399B2Fluorinated integrin antagonistsOCUTERRA THERAPEUTICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·5 claims
- 0386US11685738B2Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereofOCUTERRA THERAPEUTICS INC·Filed 2020·Granted Jun 27, 2023·1 cites·20 claims
- 0485US12286432B2Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereofOCUTERRA THERAPEUTICS INC·Filed 2023·Granted Apr 29, 2025·0 cites·20 claims
- 0564US2025367180A1Stable ophthalmic formulations of a fluorinated integrin antagonistOCUTERRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0662US11858900B2Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivativesOCUTERRA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·18 claims
- 0761US2023129394A1METHODS OF TREATING OR PREVENTING VIRAL INFECTION WITH FLUORINATED AlphaV INTEGRIN ANTAGONISTSOCUTERRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OCUTERRA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →